166 related articles for article (PubMed ID: 23805045)
1. Statistical Considerations in the Design of Biosimilar Cancer Clinical Trials.
Ahn C; Lee SC
Ungyong Tonggye Yongu; 2011 Jun; 24(3):495-503. PubMed ID: 23805045
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic equivalence of complex drugs.
Schellekens H; Klinger E; Mühlebach S; Brin JF; Storm G; Crommelin DJ
Regul Toxicol Pharmacol; 2011 Feb; 59(1):176-83. PubMed ID: 20951177
[TBL] [Abstract][Full Text] [Related]
3. Statistical and regulatory considerations in assessments of interchangeability of biological drug products.
Tóthfalusi L; Endrényi L; Chow SC
Eur J Health Econ; 2014 May; 15 Suppl 1(Suppl 1):S5-11. PubMed ID: 24832831
[TBL] [Abstract][Full Text] [Related]
4. From bioequivalence to biosimilars: How much do regulators dare?
Weise M
Z Evid Fortbild Qual Gesundhwes; 2019 Mar; 140():58-62. PubMed ID: 30622000
[TBL] [Abstract][Full Text] [Related]
5. Biosimilars: policy, clinical, and regulatory considerations.
Gottlieb S
Am J Health Syst Pharm; 2008 Jul; 65(14 Suppl 6):S2-8. PubMed ID: 18591712
[TBL] [Abstract][Full Text] [Related]
6. Statistical considerations in biosimilar clinical efficacy trials with asymmetrical margins.
Li Y; Liu Q; Wood P; Johri A
Stat Med; 2013 Feb; 32(3):393-405. PubMed ID: 22991275
[TBL] [Abstract][Full Text] [Related]
7. Some thoughts on drug interchangeability.
Chow SC; Song F; Chen M
J Biopharm Stat; 2016; 26(1):178-86. PubMed ID: 26366703
[TBL] [Abstract][Full Text] [Related]
8. Statistical assessment of biosimilar products.
Chow SC; Liu JP
J Biopharm Stat; 2010 Jan; 20(1):10-30. PubMed ID: 20077246
[TBL] [Abstract][Full Text] [Related]
9. Biosimilar safety considerations in clinical practice.
Choy E; Jacobs IA
Semin Oncol; 2014 Feb; 41 Suppl 1():S3-14. PubMed ID: 24560025
[TBL] [Abstract][Full Text] [Related]
10. Strengths and weaknesses of the Brazilian regulation on biosimilars: A critical view of the regulatory requirements for biosimilars in Brazil.
de Assis MR; Pinto V
Ther Adv Musculoskelet Dis; 2018 Dec; 10(12):253-259. PubMed ID: 30515251
[TBL] [Abstract][Full Text] [Related]
11. Biosimilars: Practical Considerations for Pharmacists.
Stevenson JG; Popovian R; Jacobs I; Hurst S; Shane LG
Ann Pharmacother; 2017 Jul; 51(7):590-602. PubMed ID: 28176529
[TBL] [Abstract][Full Text] [Related]
12. Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
Rivera VM
Neurol Ther; 2019 Dec; 8(2):177-184. PubMed ID: 31313222
[TBL] [Abstract][Full Text] [Related]
13. Biosimilar therapeutics-what do we need to consider?
Schellekens H
NDT Plus; 2009 Jan; 2(Suppl_1):i27-i36. PubMed ID: 19461855
[TBL] [Abstract][Full Text] [Related]
14. Developing clinical trials for biosimilars.
Bui LA; Taylor C
Semin Oncol; 2014 Feb; 41 Suppl 1():S15-25. PubMed ID: 24560024
[TBL] [Abstract][Full Text] [Related]
15. Anti-neoplastic biosimilars--the same rules as for cytotoxic generics cannot be applied.
Mellstedt H
Ann Oncol; 2013 Sep; 24 Suppl 5():v23-8. PubMed ID: 23975701
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence studies with anti-TNF biosimilars.
Gimeno-Gracia M; Gargallo-Puyuelo CJ; Gomollón F
Expert Opin Biol Ther; 2019 Oct; 19(10):1031-1043. PubMed ID: 30574813
[No Abstract] [Full Text] [Related]
17. Biosimilar: what it is not.
de Mora F
Br J Clin Pharmacol; 2015 Nov; 80(5):949-56. PubMed ID: 25865457
[TBL] [Abstract][Full Text] [Related]
18. [Biosimilars, the journey has begun].
Martos-Rosa A; Martínez-de la Plata JE; Morales-Molina JA; Fayet-Pérez A; Acosta-Robles PJ
Farm Hosp; 2015 Mar; 39(2):114-7. PubMed ID: 25817091
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis for bioequivalence review.
Chow SC; Liu J
J Biopharm Stat; 1997 Mar; 7(1):97-111. PubMed ID: 9056591
[TBL] [Abstract][Full Text] [Related]
20. Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins.
Combe C; Tredree RL; Schellekens H
Pharmacotherapy; 2005 Jul; 25(7):954-62. PubMed ID: 16006274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
